77 related articles for article (PubMed ID: 8263009)
1. Microsatellite instability and k-ras, p53 mutations in thyroid lymphoma.
Takakuwa T; Hongyo T; Syaifudin M; Kanno H; Matsuzuka F; Narabayashi I; Nomura T; Aozasa K
Jpn J Cancer Res; 2000 Mar; 91(3):280-6. PubMed ID: 10760686
[TBL] [Abstract][Full Text] [Related]
2. Abnormalities in structure and expression of the human retinoblastoma gene in SCLC.
Harbour JW; Lai SL; Whang-Peng J; Gazdar AF; Minna JD; Kaye FJ
Science; 1988 Jul; 241(4863):353-7. PubMed ID: 2838909
[TBL] [Abstract][Full Text] [Related]
3. Gene mutation analysis and quantitation of DNA topoisomerase I in previously untreated non-small cell lung carcinomas.
Takatani H; Oka M; Fukuda M; Narasaki F; Nakano R; Ikeda K; Terashi K; Kinoshita A; Soda H; Kanda T; Schneider E; Kohno S
Jpn J Cancer Res; 1997 Feb; 88(2):160-5. PubMed ID: 9119744
[TBL] [Abstract][Full Text] [Related]
4. P53 and Rb Aberrations in Small Cell Lung Cancer (SCLC): From Molecular Mechanisms to Therapeutic Modulation.
Papavassiliou KA; Sofianidi AA; Gogou VA; Anagnostopoulos N; Papavassiliou AG
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473726
[TBL] [Abstract][Full Text] [Related]
5. Imaging primary lung cancers in mice to study radiation biology.
Kirsch DG; Grimm J; Guimaraes AR; Wojtkiewicz GR; Perez BA; Santiago PM; Anthony NK; Forbes T; Doppke K; Weissleder R; Jacks T
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):973-7. PubMed ID: 20206017
[TBL] [Abstract][Full Text] [Related]
6. Molecular footprints of human lung cancer progression.
Yokota J; Kohno T
Cancer Sci; 2004 Mar; 95(3):197-204. PubMed ID: 15016317
[TBL] [Abstract][Full Text] [Related]
7. Amplification of the RB1.20 polymorphism in single spermatozoa.
Girardet A; Pellestor F; Tuffery S; Claustres M; Munier F; Duperray C
J Assist Reprod Genet; 1997 Mar; 14(3):177-9. PubMed ID: 9090563
[No Abstract] [Full Text] [Related]
8. α-Hederin promotes ferroptosis and reverses cisplatin chemoresistance in non-small cell lung cancer.
Han S; Yang X; Zhuang J; Zhou Q; Wang J; Ru L; Niu F; Mao W
Aging (Albany NY); 2024 Jan; 16(2):1298-1317. PubMed ID: 38244586
[TBL] [Abstract][Full Text] [Related]
9. Microfluidic purification and concentration of malignant pleural effusions for improved molecular and cytomorphological diagnostics.
Che J; Mach AJ; Go DE; Talati I; Ying Y; Rao J; Kulkarni RP; Di Carlo D
PLoS One; 2013; 8(10):e78194. PubMed ID: 24205153
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanism underlying the antiproliferative effect of suppressor of cytokine signaling-1 in non-small-cell lung cancer cells.
Shimada K; Serada S; Fujimoto M; Nomura S; Nakatsuka R; Harada E; Iwahori K; Tachibana I; Takahashi T; Kumanogoh A; Kishimoto T; Naka T
Cancer Sci; 2013 Nov; 104(11):1483-91. PubMed ID: 23962256
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitors downregulate checkpoint kinase 1 expression to induce cell death in non-small cell lung cancer cells.
Brazelle W; Kreahling JM; Gemmer J; Ma Y; Cress WD; Haura E; Altiok S
PLoS One; 2010 Dec; 5(12):e14335. PubMed ID: 21179472
[TBL] [Abstract][Full Text] [Related]
12. A gene-alteration profile of human lung cancer cell lines.
Blanco R; Iwakawa R; Tang M; Kohno T; Angulo B; Pio R; Montuenga LM; Minna JD; Yokota J; Sanchez-Cespedes M
Hum Mutat; 2009 Aug; 30(8):1199-206. PubMed ID: 19472407
[TBL] [Abstract][Full Text] [Related]
13. The retinoblastoma protein is required for Ras-induced oncogenic transformation.
Williams JP; Stewart T; Li B; Mulloy R; Dimova D; Classon M
Mol Cell Biol; 2006 Feb; 26(4):1170-82. PubMed ID: 16449633
[TBL] [Abstract][Full Text] [Related]
14. Multiple changes in oncogenes and tumor suppressor genes in human retinoblastoma.
Howard RO
Trans Am Ophthalmol Soc; 1996; 94():299-312; discussion 312-4. PubMed ID: 8981702
[TBL] [Abstract][Full Text] [Related]
15. Gene analysis of K-, H-ras, p53, and retinoblastoma susceptibility genes in human lung cancer cell lines by the polymerase chain reaction/single-strand conformation polymorphism method.
Kashii T; Mizushima Y; Monno S; Nakagawa K; Kobayashi M
J Cancer Res Clin Oncol; 1994; 120(3):143-8. PubMed ID: 8263009
[TBL] [Abstract][Full Text] [Related]
16. A universal method for the mutational analysis of K-ras and p53 gene in non-small-cell lung cancer using formalin-fixed paraffin-embedded tissue.
Sarkar FH; Valdivieso M; Borders J; Yao KL; Raval MM; Madan SK; Sreepathi P; Shimoyama R; Steiger Z; Visscher DW
Diagn Mol Pathol; 1995 Dec; 4(4):266-73. PubMed ID: 8634783
[TBL] [Abstract][Full Text] [Related]
17. p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features.
Mitsudomi T; Steinberg SM; Nau MM; Carbone D; D'Amico D; Bodner S; Oie HK; Linnoila RI; Mulshine JL; Minna JD
Oncogene; 1992 Jan; 7(1):171-80. PubMed ID: 1311061
[TBL] [Abstract][Full Text] [Related]
18. Coincidental alterations of p16INK4A/CDKN2 and other genes in human lung cancer cell lines.
Fujishita T; Mizushima Y; Kashii T; Kobayashi M
Anticancer Res; 1998; 18(3A):1537-42. PubMed ID: 9673367
[TBL] [Abstract][Full Text] [Related]
19. Overview of genetic and molecular events in the pathogenesis of lung cancer.
Johnson BE; Kelley MJ
Chest; 1993 Jan; 103(1 Suppl):1S-3S. PubMed ID: 8380130
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
